Abstract # 2253 High Dose Rate (HDR) Monotherapy is Equivalent to Combined HDR Brachytherapy and External Beam Radiation Therapy (EBRT) for Early Prostate Cancer

Presenter: Demanes, D. Jeffrey

< Back to topics

> Cover Page, Authors, Institutions

> Purpose/Objective

> Materials/Methods

> Results/Discussion

> Conclusions

> View tables/images/videos

About the Presenter:
D. Jeffrey Demanes, M.D. founded California Endocurietherapy Cancer Center (CET) in 1981. He graduated from the University of California, Los Angeles (UCLA) Medical School where he also served his residencies in internal medicine and oncology. From 1978-1981 he held fellow-ships at UCLA, and the University of CaliforČnia, San Francisco (UCSF), and at Memorial Hospital in Long Beach. Dr. Demanes is board certified in three medical specialiČties: Radiation Oncology, Medical Oncology, and Internal Medicine. He is on the voluntary clinical staff at Stanford University and UCLA medical centers. He is presently serving as President of the American College of Radiation Oncology (ACRO) and is a member of various governmental liaison committees for the AmeriČcan Society for Therapeutic Radiology and Oncology (ASTRO). Stanford University Medical Center requested that CET become a clinical affiliate in their residency program. Stanford residents now rotate through CET for their HDR brachytherapy training.

Authors:
D. Demanes*, G. Altieri*, M. Barnaba*, D. Brandt*, D. Hill*, L. Schour*. , CA Endocurietherapy Medical Corp., Oakland, CA,

Author Disclosure:
D. Demanes, None; G. Altieri, None; M. Barnaba, None; D. Brandt, None; D. Hill, None; L. Schour, None.

Click on images to enlarge (a new pop-up window will open)

CET ASTRO Poster 2006:



E-mail a friend about this abstract:
Enter email address:   



Abstracts Main Page | Logout